Wednesday 29 July 2015

Hikma to acquire Roxane for $2.65bn

Hikma Pharmaceuticals, a leading multinational pharmaceutical group, is set to acquire Roxane Laboratories and Boehringer Ingelheim Roxane, from Boehringer Ingelheim. The acquisition has an aggregate value of gross consideration of about $2.65 billion, sad a statement.


Teva to take over Allergan generic business for $40.5bn

Teva Pharmaceutical Industries will pay $40.5 billion in cash and stock for Allergan’s generic drugs business, solidifying Teva's position as the world's No. 1 maker of generics while freeing Allergan to focus on branded drugs, paying down debt and potential “transformationa


S Korea declares country out of Mers danger

South Korea declared on Tuesday it is effectively out of danger from Middle East Respiratory Syndrome (Mers), more than two months after the first case was reported and began spreading in hospital settings to kill 36 people. The outbreak grew to become the largest outside Saudi A


Plea to increase staff at Bahrain’s main hospital

A shortage of staff at Bahrain’s main hospital during weekends and public holidays is causing unnecessary suffering to sickle cell anaemia patients, an activist has claimed. Bahrain Society for Sickle Cell Anaemia Patient Care president Zakreya Al Kadhem said that sickle ce


1,200 experts for UAE Cancer Congress

More than 1,200 oncologists and allied healthcare professionals will learn and network with cancer specialists from around the globe at the upcoming UAE Cancer Congress in Dubai. The event takes place from October 29 to 31 at the InterContinental Hotel Festival City.


Vertical Progress in deal to distribute Obagi in UAE

Cellogique Corporation, a leader in cosmetic surgery, medical aesthetics, and skin health in the Middle East, has established a new partnership with Vertical Progress Trading Company to distribute Obagi Medical Products, a division of Valeant Pharmaceuticals. Obagi is a renowned


Abu Dhabi meet to focus on osteoporosis, diabetes

Osteoporosis and diabetes - two serious chronic disease - are affecting a growing proportion of the population in the Middle East, due to the ageing of the population and increasingly unhealthy lifestyles. In response to the increase in these diseases within the region, the Inter


Mouwasat Medical Q2 net profit falls 6pc

Mouwasat Medical Services Company, one of Saudi Arabia's largest listed healthcare firms, on Monday blamed a 5.6 per cent fall in second-quarter net profit on losses from a recently opened hospital as its earnings missed analyst forecasts. The company made a net profit of SR5


Bahrain health officials warn about organ trade mafias

Health officials have issued a stark warning about the dangers of medical tourism as growing numbers of Bahrainis look abroad for kidney transplants. Since 1997, when the Health Ministry opened its Yusuf Khalil Almoayyed Nephrology and Renal Transplant Centre at Salmaniya Medical


Air Arabia, Sharjah hospital sign service level deal

Air Arabia has signed a service level agreement with University Hospital Sharjah outlining a broad framework for healthcare services and education for the airline’s staff. As part of the agreement, the hospital will determine the primary, secondary and tertiary care needs o

 1 2 3 > 

calendarCalendar of Events